Literature DB >> 31117092

Evaluation of Clinical Outcome and Risk Factors for Recurrence after Pelvic Reconstruction of Pelvic Organ Prolapse with Implanted Mesh or Biological Grafts: A Single-Blind Randomized Trial.

Ai-Min Wei1, Yun Fan2,3, Lei Zhang4, Yu-Fei Shen4, Qing Kou4, Xiao-Mei Tan4.   

Abstract

BACKGROUND: There are few studies on the relative factors related to postoperative recurrence.
OBJECTIVES: To compare the outcomes of pelvic floor reconstruction involving Herniamesh mesh and biological grafts and to investigate the correlative factors of postoperative recurrence.
METHOD: Two hundred and thirty-two patients were randomly divided into 2 groups: Herniamesh mesh group (117) and biological graft group (115). Follow-ups for 6 months and 1 year after the surgery. The primary outcomes were recurrence, perioperative complications. Secondary outcome was a questionnaire about the life habits associated with relapse.
RESULTS: The recurrence rate at 6 months or 1 year did not differ substantially between the 2 groups (p = 0.787 and 0.968, respectively). Adverse events occurred with significantly different frequencies over 1 year (p = 0.005). Twelve factors were investigated and analyzed by logistic regression analysis. It showed that recurrence had a strong association with a long-term vegetarian diet (OR 0.283, 95% CI 0.117-0.683), long-term soybean product diet (OR 8.010, 95% CI 2.514-25.523), and vaginal intercourse (OR 5.154, 95% CI 1.461-18.184).
CONCLUSIONS: The surgical recurrence rate for the mesh was similar to biological grafts at short-term follow-up. Eating soy products often and vaginal intercourse after surgery can reduce recurrence.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Pelvic organ prolapse; Postoperative complications; Recurrence; Risk factors

Mesh:

Year:  2019        PMID: 31117092     DOI: 10.1159/000500674

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  1 in total

1.  Primary paediatric chest wall tumours necessitating surgical management.

Authors:  N Maistry; J Durell; S Wilson; K Lakhoo
Journal:  Ann R Coll Surg Engl       Date:  2020-03-11       Impact factor: 1.891

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.